3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
13
Carcinoma, Renal Cell
10
Carcinoma, Non-Small-Cell Lung
6
Carcinoma, Transitional Cell
4
Neoplasms
3
Neoplasm Metastasis
3
Clear-cell metastatic renal cell carcinoma
3
Carcinoma, Hepatocellular
3
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Multiple Myeloma
2
Lung Neoplasms
2
Kidney Neoplasms
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Somatostatinoma
1
Skin Neoplasms
1
Seminoma
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Interventions
Cyclophosphamide
11
Biopsy
11
Specimen Handling
10
Rituximab
9
Magnetic Resonance Spectroscopy
9
obinutuzumab
6
fludarabine
6
Prednisone
6
Lenalidomide
6
pembrolizumab
5
Nuclear Medicine Department, Hospital
5
X-Rays
4
Doxorubicin
4
venetoclax
3
fludarabine phosphate
3
Vincristine
3
Tacrolimus
3
Mycophenolic Acid
3
GSK2636771
3
Etoposide
3
Busulfan
3
Bendamustine Hydrochloride
3
trametinib
2
tocilizumab
2
palbociclib
2
osimertinib
2
ipatasertib
2
ibrutinib
2
glofitamab
2
erdafitinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Ipilimumab
×
30 days
×
Clear all
No trials found.